A case of sporadic Creutzfeldt – Jakob disease and discussion on diagnostic biomarkers

1. Prusiner SB, Neurodegenerative diseases and prions, N Engl J Med. 2001;344:1516-26.10.1056/NEJM200105173442006Search in Google Scholar

2. Gambetti P, Kong Q, Zou W, Parchi P, G Chen SG, Sporadic and familial CJD: classification and characterization, British Medical Bulletin. 2003;66, 214.Search in Google Scholar

3. Sadowski M, Verma A, Wisniewski T, Chapter 59. Infectious of the nervous system. Prion Diseases, in Bradley WG, Daroff RB, Fenichel GM, Jankovic J, Neurology in clinical practice, Elsevier. 2004;II:1616-17.Search in Google Scholar

4. Beauvais P, Billette de Villemeur T, Maladie à prion ou encéphalopathies spongiformes transmissibles, Encyclopédie medico - chirurgicale. 17-056-a-40:10-14.Search in Google Scholar

5. Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heidemann U et al., Updated Clinical Diagnostic Criteria for Sporadic Creutzfeldt - Jakob disease, Brain 2009;132:2659-2668.Search in Google Scholar

6. WHO Infection Control Guidelines for Transmissible Encephalopathies Geneva, Switzerland, 1999: who.int/csr/publication/bse/who_cds_csr_aph_2000_3/en.Search in Google Scholar

7. Javed Q, Alam FS., Jaganathan G, An unusual case of sporadic Creutzfeldt-Jakob disease (CJD), BMJ Case Rep. 2010;PMCID: PMC3047567.10.1136/bcr.12.2009.2576Search in Google Scholar

8. Jansen C, Parchi P, Capellari S, Human HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/22558438"prion-HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/22558438" diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects, PLoS One. 2012;7(4):e36333; PMID:22558438.10.1371/journal.pone.0036333Search in Google Scholar

9. Hachiya NS, Imagawa M, Kaneko, K, The possible role of protein X, a putative auxiliary factor in pathological prion replication, in regulating a physiological endoproteolytic cleavage of cellular prion protein. Med. Hypotheses, 2007;68(3):670-63.10.1016/j.mehy.2006.07.038Search in Google Scholar

10. Olanow CW, Brundin P, Parkinson’s disease and alpha synuclein: is Parkinson’s disease a prion-like disorder?, Mov Disord, 2013;28:31-40.doi: 10.1002/mds.25373.10.1002/mds.25373Search in Google Scholar

11. Tayebi M, Jones DR, Taylor WA, Stileman BF, Chapman C, Zhao D, David M, PrPSc-Specific Antibodies with the Ability to Immunodetect Prion Oligomers, PLoS ONE 2011;6(5): e19998. doi:10.1371/journal.- pone.0019998.Search in Google Scholar

12. Obsil T, Ghirlando R, Klein DC, Ganguly S, Dyda F. Crystal structure of the 14-3-3 zeta: serotonin N-acetyltransferase complex. A role for scaffolding in enzyme regulation, Cell 2001, Apr 20;105(2):257-67.10.1016/S0092-8674(01)00316-6Search in Google Scholar

13. Baert LA, Knauth M, Inflammatory Diseases of the Brain, Springer 2009:113-123.Search in Google Scholar

14. Beaudry P, Cohen P, Brandel JP, Delasnerie - Lauprêtre N, Richard S, Launay JM, Laplanche JL, 14-3-3 protein, neuron specific enolase and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease, Dement Geriatr Cogn Disorder. 1999 Jan- Feb;10(1):40-6.10.1159/000017095Search in Google Scholar

15. Reiniger L, Lukic A, Linehan J, Rudge P, Colinge J, Mead S, Bradner S, Tau, prions and Aβ: the triad of neurodegeneration, Acta Neuropathol. 2011 Jan;121(1):5-20.10.1007/s00401-010-0691-0Search in Google Scholar

16. Vander T, Hallevy T, Alsaed I, Valdman S, Ifergane G, Wirguin I, 14-3-3 protein in the CSF of a patient with Hashimoto’s encephalopathy, J Neurol. 2004 Oct; 251(10):1273-1274.10.1007/s00415-004-0515-zSearch in Google Scholar

17. Süssmuth SD, Hansoto R, Tumani H, Tau protein in CSF: a blood-CSF barrier related evaluation in patients with various neurological diseases, Neuroscience Letters, 2001; 300:95-98.10.1016/S0304-3940(01)01556-7Search in Google Scholar

18. Ferenczy MW, Marshall LJ, Nelson CD, Atwood WJ, Nath A, Khalili K, Major EO, Molecular biology, epidemiology and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the brain. Clin Microbiol Rev. 2012 Jul;25(3):471-506. doi:10.1128/CMR.0503-11.Search in Google Scholar

19. Schröter A, Zerr I, Henkel K, Tschampa HJ Finkelstaedt M, Poser S, Magnetic resonance imaging in diagnosis of Creutzfeldt-Jakob disease, Arch Neurol 2000;57:1751-1757.10.1001/archneur.57.12.175111115241Search in Google Scholar

20. Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RS, et al. Analysis of EEG and proteins as aids to the diagnosis of Creutzfeldt-Jakob disease, Neurology 2000;55:811-815.Search in Google Scholar

21. Louie JK, Gavali SS, Belay ED, Trevejo R, Hammond LH, Schonberger LB, et al. Barriers to Creutzfeldt- Jakob disease autopsies, California. Emerg Infect Dis. 2004 Sep; 10(9): 1677-80.10.3201/eid1009.040066332031215498177Search in Google Scholar

22. Ironside JW, Head M, Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease, Curr Top Microbiol Immunol 2004;284:133-59.10.1007/978-3-662-08441-0_615148991Search in Google Scholar

23. Kovács GG, Majtényi K, László L, Prion protein immunohistochemistry in Creutzfeldt-Jakob disease, Pathol Oncol Res 1997 Sep 3(3):193-7.10.1007/BF0289992018470729Search in Google Scholar

24. Tschampa JH, Herms J, Schultz-Schaeffer WJ, Maruschak B, Windl O, Jastrow U, et al., Clinical findings in sporadic Creutzfeldt-Jakob disease correlate with thalamic pathology, Brain 2002;125(11):2558-66.Search in Google Scholar

25. Johnson CJ, Pedersen JA, Chappell RJ, McKenzie D, Aiken JM, Oral Transmissibility of Prion Disease Is Enhanced by Binding to Soil Particles, PLoS Pathog, 2007;3(7): e93. doi:10.1371/journal.ppat.0030093.10.1371/journal.ppat.0030093190447417616973Search in Google Scholar